Search research articles
Contact Us
Filters
Showing results (11-20 of 150) with videos related to
Page
of 15
Sort By:
International Journal of Clinical Oncology
|
September 18, 2024
Pembrolizumab in Japanese patients with primary mediastinal large B-cell lymphoma: results from the KEYNOTE-A33 study
Koji Kato, Sosuke Nakamura, Akira Wakana, et al.
Cancer Research
|
August 3, 2005
Halogenated thymidine analogues restore the expression of silenced genes without demethylation
Jun Fan, Ei-ichi Kodama, Yasuhiro Koh, et al.
Journal of Chemical Information and Modeling
|
November 26, 2009
Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model
Debananda Das, Yasuhiro Koh, Yasushi Tojo, et al.
Clinical Lung Cancer
|
January 7, 2019
A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L)
Hiroaki Akamatsu, Shunsuke Teraoka, Yasuhiro Koh, et al.
Cancer Science
|
April 5, 2014
Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells
Masakuni Serizawa, Haruyasu Murakami, Masaru Watanabe, et al.
Anticancer Research
|
April 3, 2020
Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells
Takehito Shukuya, Jun Oyanagi, Masakuni Serizawa, et al.
Current Opinion in Pharmacology
|
September 8, 2004
The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection
Kenji Maeda, Hirotomo Nakata, Hiromi Ogata, et al.
Scientific Reports
|
July 10, 2019
Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition
Masayuki Amano, Haydar Bulut, Sadahiro Tamiya, et al.
Cancer Science
|
December 15, 2004
Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models
Fumiko Taguchi, Yasuhiro Koh, Fumiaki Koizumi, et al.
The Journal of Biological Chemistry
|
March 27, 2004
Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility
Yukiko Ueda, Shizhen Wang, Nancy Dumont, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 150) with videos related to
Sort By:
Page
of 15
International Journal of Clinical Oncology
|
September 18, 2024
Pembrolizumab in Japanese patients with primary mediastinal large B-cell lymphoma: results from the KEYNOTE-A33 study
Koji Kato, Sosuke Nakamura, Akira Wakana, et al.
Cancer Research
|
August 3, 2005
Halogenated thymidine analogues restore the expression of silenced genes without demethylation
Jun Fan, Ei-ichi Kodama, Yasuhiro Koh, et al.
Journal of Chemical Information and Modeling
|
November 26, 2009
Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model
Debananda Das, Yasuhiro Koh, Yasushi Tojo, et al.
Clinical Lung Cancer
|
January 7, 2019
A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L)
Hiroaki Akamatsu, Shunsuke Teraoka, Yasuhiro Koh, et al.
Cancer Science
|
April 5, 2014
Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells
Masakuni Serizawa, Haruyasu Murakami, Masaru Watanabe, et al.
Anticancer Research
|
April 3, 2020
Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells
Takehito Shukuya, Jun Oyanagi, Masakuni Serizawa, et al.
Current Opinion in Pharmacology
|
September 8, 2004
The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection
Kenji Maeda, Hirotomo Nakata, Hiromi Ogata, et al.
Scientific Reports
|
July 10, 2019
Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition
Masayuki Amano, Haydar Bulut, Sadahiro Tamiya, et al.
Cancer Science
|
December 15, 2004
Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models
Fumiko Taguchi, Yasuhiro Koh, Fumiaki Koizumi, et al.
The Journal of Biological Chemistry
|
March 27, 2004
Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility
Yukiko Ueda, Shizhen Wang, Nancy Dumont, et al.
Page
of 15